Optimal use of perampanel in asian patients with epilepsy: Expert opinion

Yotin Chinvarun, Chin Wei Huang, Ye Wu, Hsiu Fen Lee, Surachai Likasitwattanakul, Jing Ding, Takamichi Yamamoto

研究成果: Review article同行評審

11 引文 斯高帕斯(Scopus)


Perampanel is a once-daily, first-in-class AMPA receptor antagonist approved for the treatment of epilepsy and exhibits broad-spectrum efficacy in a range of seizure types when used as both monotherapy and adjunctive therapy. Clinical studies and real-world evidence have demonstrated the advantages of initiating perampanel at low doses and utilizing a slow titration strategy. Initiating perampanel at an early stage has also been shown to be associated with better patient outcomes. However, the optimal use and place of perampanel in clinical practice has not yet been clearly defined for the Asian patient population. Use of perampanel in clinical practice varies markedly across the Asia region because of variation in knowledge, attitudes, and practice. There is currently no specific guidance on best practices for prescribing perampanel in Asian patients or how to optimize treatment strategies to maximize adherence. A group of epilepsy experts attended a virtual meeting in September 2020 to discuss their experience with using perampanel in the Asian practice setting, including their views regarding appropriate patient populations, optimal starting and maintenance doses, optimal titration regimens, key barriers to adherence, and prevention and management of adverse events. This article summarizes key clinical and real-world evidence for perampanel and consolidates the experts’ opinions on optimization of perampanel prescribing and adherence in real-world practice, providing practical strategies for clinicians to implement to improve outcomes for people with epilepsy in Asia.

頁(從 - 到)739-746
期刊Therapeutics and Clinical Risk Management
出版狀態Published - 2021

All Science Journal Classification (ASJC) codes

  • 一般藥理學、毒理學和製藥學
  • 藥學(醫學)
  • 化學健康與安全
  • 安全研究


深入研究「Optimal use of perampanel in asian patients with epilepsy: Expert opinion」主題。共同形成了獨特的指紋。